ACLS Price Prediction Next Week
Analysis and Insights
To predict the stock price of Axcelis Technologies (ACLS) for the next trading week, we will analyze both technical indicators and recent news sentiment.
Technical Analysis:
The current price of ACLS is $58.17 as of March 13, 2025. Key technical indicators include:
- RSI (14): 42.26, indicating the stock is oversold and potentially due for a bounce.
- MACD: -2.03, showing bearish momentum.
- Stochastic Oscillator: Oversold territory, with %K (40.42) below %D (44.54).
- Fibonacci Levels:
- Resistance: $60.47, $62.25
- Support: $54.72, $52.94
News Sentiment Analysis:
- Analyst Downgrade: DA Davidson lowered ACLS's price target from $125 to $100, citing disappointing Q1 outlook and increased operating expenses.
- Mixed Analyst Ratings: While some firms like D.A. Davidson maintain a Buy rating, others like William Blair have downgraded to Hold.
- Valuation Upgrade: Validea's Benjamin Graham strategy upgraded ACLS to 86%, indicating strong value fundamentals.
Price Prediction:
Given the oversold RSI and potential for a short-term bounce, ACLS may see a slight recovery. However, the overall bearish MACD and analyst downgrades suggest limited upside. The stock is likely to trade between $55 and $62 next week.
Recommendation:
Sell ACLS next week with a target price of $55.00 and a stop-loss at $60.00.
ACLS Similar Chart Price Prediction
The price of ACLS is predicted to go up -1.5%, based on the high correlation periods with SONY. The similarity of these two price pattern on the periods is 96.07%.
ACLS
SONY
Down: -1.5%Similarity: 96.07%
ACLS Revenue Forecast
ACLS EPS Forecast
ACLS FAQs
What is ACLS revenue forecast for next quarter？
What is ACLS eps forecast for next quarter？
ACLS Analyst's Forecast
Jed Dorsheimer
William Blair
Buy → Hold
2025-02-12
Price Target
n/a
Downside
0%
William Blair downgraded Axcelis to Market Perform from Outperform. The growth story of silicon carbide has "changed materially" as EV demand has remained weak outside of China and there is limited visibility on a recovery, the analyst tells investors. The firm sees risk to the company's 2027 targets, the analyst added.
